The LEADLESS II IDE Study (Phase I): Safety and Effectiveness Trial for the Nanostim Leadless Pacemaker
Phase: NA
Conditions: Bradycardia
Sponsor: Abbott Medical Devices

Clinical Investigation Plan Cover Page 
This confidential document is the property of Abbott and shall not be reproduced, distributed, disclosed or used without the 
express written consent of Abbott. 
87173 CIP Posting Cover Page Ver C 
Template 
Page 1 of 1 
NCT Number: NCT02030418 
The LEADLESS II Study 
A safety and effectiveness trial for a leadless pacemaker system 
Study Document No: SJM-CIP-10226 
Version L 
Date: 8-JUL-2019 
Sponsor 
St. Jude Medical (now Abbott) 
Cardiac Rhythm Management 
15900 Valley View Court 
Sylmar, CA  91342 
U.S.